King DF - Search Results

1

Studies with the schistosomicide oxamniquine (UK-4271). II. Activity in primates.

Foster R, Cheetham BL, King DF. Foster R, et al. Among authors: king df. Trans R Soc Trop Med Hyg. 1973;67(5):685-93. doi: 10.1016/0035-9203(73)90039-4. Trans R Soc Trop Med Hyg. 1973. PMID: 4205106 No abstract available.

2

The action of UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative, against mature schistosomes in rodents and primates.

Foster R, Cheetham BI, King DF, Mesmer ET. Foster R, et al. Among authors: king df. Ann Trop Med Parasitol. 1971 Mar;65(1):59-70. doi: 10.1080/00034983.1971.11686730. Ann Trop Med Parasitol. 1971. PMID: 4995890 No abstract available.

3

The control of immature Schistosoma mansoni in mice by UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative.

Foster R, Mesmer ET, Cheetham BL, King DF. Foster R, et al. Among authors: king df. Ann Trop Med Parasitol. 1971 Jun;65(2):221-32. doi: 10.1080/00034983.1971.11686749. Ann Trop Med Parasitol. 1971. PMID: 5104500 No abstract available.

4

Comparative studies of the action of mirasan, lucanthone, hycanthone and niridazole against Schistosoma mansoni in mice.

Foster R, Cheetham BL, Mesmer ET, King DF. Foster R, et al. Among authors: king df. Ann Trop Med Parasitol. 1971 Mar;65(1):45-58. doi: 10.1080/00034983.1971.11686729. Ann Trop Med Parasitol. 1971. PMID: 5575897 No abstract available.

5

The therapeutic activity of some nitrofurans in experimental filariasis and trypanosomiasis.

Foster R, Pringle G, King DF, Paris J. Foster R, et al. Among authors: king df. Ann Trop Med Parasitol. 1969 Mar;63(1):95-107. doi: 10.1080/00034983.1969.11686604. Ann Trop Med Parasitol. 1969. PMID: 4980716 No abstract available.

6

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary.

King DF, Groves H, Weller C, Jones I, Cramer JP, Gilbert PB, Goldblatt D, Gruber MF, Kampmann B, Maïga D, Pasetti MF, Plotkin SA, Precioso A, Wassie L, Wittke F, Kaslow DC. King DF, et al. NPJ Vaccines. 2024 Apr 29;9(1):82. doi: 10.1038/s41541-024-00872-6. NPJ Vaccines. 2024. PMID: 38684704 Free PMC article.

7

The role of correlates of protection in overcoming barriers to vaccine development and demonstrating efficacy.

King DF, Groves H, Weller C. King DF, et al. NPJ Vaccines. 2024 Apr 13;9(1):78. doi: 10.1038/s41541-024-00873-5. NPJ Vaccines. 2024. PMID: 38615121 Free PMC article. No abstract available.

8

Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report.

Knisely JM, Buyon LE, Mandt R, Farkas R, Balasingam S, Bok K, Buchholz UJ, D'Souza MP, Gordon JL, King DFL, Le TT, Leitner WW, Seder RA, Togias A, Tollefsen S, Vaughn DW, Wolfe DN, Taylor KL, Fauci AS. Knisely JM, et al. Among authors: king dfl. NPJ Vaccines. 2023 Apr 12;8(1):53. doi: 10.1038/s41541-023-00654-6. NPJ Vaccines. 2023. PMID: 37045860 Free PMC article.

9

Human infection studies: Key considerations for challenge agent development and production.

Balasingam S, Meillon S, Chui C, Mann A, La C, Weller CL, King DF, Smith E. Balasingam S, et al. Among authors: king df. Wellcome Open Res. 2022 Apr 22;7:140. doi: 10.12688/wellcomeopenres.17869.1. eCollection 2022. Wellcome Open Res. 2022. PMID: 35505774 Free PMC article.

10

HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells.

Dalel J, Ung SK, Hayes P, Black SL, Joseph S, King DF, Makinde J, Gilmour J; The IAVI Protocol C investigators list. Dalel J, et al. Among authors: king df. AIDS. 2021 Jul 1;35(8):1167-1177. doi: 10.1097/QAD.0000000000002864. AIDS. 2021. PMID: 33710028 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page